Afimoxifene Completed Phase 2 Trials for Ductal Breast Carcinoma In Situ / Estrogen Receptor-Positive Breast Cancer / Estrogen Receptor Positive Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT009527314-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ